Infection prevention company Nanosonics has received US Food and Drug Administration clearance for its latest trophon innovation, enabling the commercial launch of trophon3 and trophon2 Plus in the United States, according to an announcement on Tuesday. The new trophon3 technology delivers over 40 per cent faster cycle times compared to previous generations whilst maintaining the…
RMIT University engineers have created a new 3D-printed titanium alloy that is 29 per cent cheaper to produce than standard titanium whilst delivering improved strength and performance, according to research published on Monday. The team replaced expensive vanadium with readily available alternative materials to reduce costs. Lead researcher Ryan Brooke said the breakthrough addresses key…
Archer Materials has achieved accuracy improvements in its blood potassium biosensor and successfully demonstrated lithium ion detection, according to a company announcement on Monday. The Adelaide-based semiconductor company said its Sydney engineering team has made measurable improvements to the sensor’s accuracy while building on early test results from February. The biosensor is designed to measure…
The National Reconstruction Fund Corporation has committed $150 million to Brandon Capital to accelerate Australian medical innovation commercialisation, according to an announcement on Thursday. The investment will be allocated to Brandon Capital’s BioCatalyst 6 fund and will support early and late-stage Australian medical science companies developing therapeutics, medical devices and vaccines. NRFC chief executive David…
Infection prevention company Nanosonics announced on Monday the launch of trophon3, its latest innovation in ultrasound high level disinfection, alongside a software upgrade package for existing customers. The company launched trophon3 and trophon2 Plus in Europe, the United Kingdom, Australia and New Zealand. A regulatory application has been submitted to the US Food and Drug…
Medical device company EMVision announced on Tuesday that five of its six pivotal trial sites are now actively enrolling and scanning patients for its bedside brain scanner, marking a significant milestone in the company’s quest to revolutionise stroke diagnosis. The Sydney-based company’s emu bedside brain scanner is being tested across leading hospitals in the United…
The Australian Government announced on Monday it would invest $12 million to develop new Australian-made medical devices and medicine for people with cardiovascular disease and diabetes. Fourteen Australian start-up and innovator companies will receive funding and commercialisation support to develop improved treatment for management of cardiovascular disease and complications of type 1 and 2 diabetes.…
Alexandria-based medical device manufacturer ProMed Australia raised more than $16,000 for the Sydney Breast Cancer Foundation at a charity auction in Pyrmont on Wednesday night, June 4. The event at Audrey Fine Art gallery featured the auction of a landscape painting by artist Ted Lewis, which sold for $4,800 despite being valued at $8,000. The…
Brain imaging company EMVision Medical Devices has revealed what it called ‘exceptional’ results for its world-first emu scanner to identify stroke and stroke type. In total 307 participants were enrolled in the EMView trial and scanned with the EMVision emu brain scanner (pictured) at Liverpool Hospital, Royal Melbourne Hospital and the Princess Alexandra Hospital, including…
Optiscan Imaging and Monash University have agreed to work together on its its project to develop the next-gen gastrointestinal (GI) flexible endomicroscope and Edge-AI-enabled technology. The agreement represents a further extension of the longstanding relationship Optiscan has with Monash University, with the company’s technology originally created at the university. AI capabilities are critical to Optiscan’s…